Literature DB >> 28238164

Excessive serous retinal detachment during the use of isotretinoin.

Mehmet Citirik1, Kemal Tekin2.   

Abstract

PURPOSE: To report a case unilateral excessive subretinal fluid during the use of isotretinoin.
METHOD: A case report. A patient who used isotretinoin orally for nodular-cystic acne vulgaris developed concurrent unilaterally excessive subretinal fluid and serous retinal detachment.
RESULTS: Fluorescein angiography did not demonstrate the leakage points throughout the subretinal fluid. Spectral-domain optical coherence tomography showed the excessive subretinal fluid and serous retinal detachment at macula. Two weeks after presentation, visual acuity was partially increased and subretinal fluid was disappeared at macula.
CONCLUSION: İsotretinoin may affect the functioning of the RPE and can cause the development of subretinal fluid and serous retinal detachment.

Entities:  

Keywords:  Acne; Isotretinoin; Subretinal fluid

Mesh:

Substances:

Year:  2017        PMID: 28238164     DOI: 10.1007/s10792-017-0482-x

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  10 in total

1.  Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane.

Authors:  Alpa Ahir; Li Guo; Ali A Hussain; John Marshall
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-02       Impact factor: 4.799

Review 2.  Effects of Isotretinoin on Meibomian Glands.

Authors:  Allison Moy; Nancy A McNamara; Meng C Lin
Journal:  Optom Vis Sci       Date:  2015-09       Impact factor: 1.973

3.  On the cause of serous detachments and acute central serous chorioretinopathy.

Authors:  M Marmor
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

4.  Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.

Authors:  Roxana A Radu; Nathan L Mata; Steven Nusinowitz; Xinran Liu; Paul A Sieving; Gabriel H Travis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

5.  Ocular adverse effects of systemic treatment with isotretinoin.

Authors:  Meira Neudorfer; Inbal Goldshtein; Orna Shamai-Lubovitz; Gabriel Chodick; Yuval Dadon; Varda Shalev
Journal:  Arch Dermatol       Date:  2012-07

6.  Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.

Authors:  Marius Rademaker
Journal:  Australas J Dermatol       Date:  2010-11       Impact factor: 2.875

7.  Regulation of beta-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA.

Authors:  J R Hadcock; C C Malbon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Premacular hemorrhage due to isotretinoin use.

Authors:  Halil Ibrahim Onder; Hakan Turan; Ali Cagri Kilic; Murat Kaya; Murat Tunc
Journal:  Cutan Ocul Toxicol       Date:  2012-04-17       Impact factor: 1.820

9.  Causes of macular serous retinal detachments in Japanese patients 40 years and older.

Authors:  Taiichi Hikichi; Hideo Ohtsuka; Makoto Higuchi; Takuro Matsushita; Hiroko Ariga; Shoko Kosaka; Reiko Matsushita
Journal:  Retina       Date:  2009-03       Impact factor: 4.256

10.  Retinol and retinoic acid increase MMP-2 activity by different pathways in cultured Sertoli cells.

Authors:  Rodrigo J S Dalmolin; Alfeu Zanotto-Filho; Ramatis B De Oliveira; Roxane F Duarte; Matheus A B Pasquali; José C F Moreira
Journal:  Free Radic Res       Date:  2007-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.